← Theranostic Atlas Therapy radar Imaging radar All targets Molecules Français Molecules
Tetrofosmin Target Myocardial perfusion Class Lipophilic cationic technetium complex (diphosphine)
0 ongoing trials
1 radiolabelled forms
1 approved products
1,633 publications (PubMed)
Structure 3D 2D
Structure from the cited PubChem record (unlabelled ligand, or the labelled form when PubChem only describes that one). Conformer: RDKit (computed conformer, indicative). Rotate with the mouse or a finger.
Properties (PubChem) Molecular formula C18H40O4P2 Molar mass (g/mol) 382.5 Exact mass (Da) 382.2402 XLogP 0.5 H-bond donors 0 H-bond acceptors 4 Rotatable bonds 19 Heavy atoms 24 InChIKey QCWJONLQSHEGEJ-UHFFFAOYSA-N PubChem record CID 4274 ↗ IUPAC name 2-[bis(2-ethoxyethyl)phosphanyl]ethyl-bis(2-ethoxyethyl)phosphane SMILES CCOCCP(CCOCC)CCP(CCOCC)CCOCC Radiolabelled forms Form Use Molar mass (labelled form) Ongoing trials Most advanced phase Approval [⁹⁹ᵐTc]Tc-tetrofosmin Syntheses and QC ↗ Imaging 899.8 0 — SPECT perfusion (sestamibi, tetrofosmin, thallium) US EU FR JP
Other trials listing it among the interventions (comparator, associated scan) · 1 1,633 publications in PubMed for the query below; the most recent:
tetrofosmin[tiab]
Comparative diagnostic performance of [(18)F] flurpiridaz PET and SPECT myocardial perfusion imaging (MPI): a systematic review and meta-analysis Eur J Nucl Med Mol Imaging, 2026 Pancreatic Uptake on 99m Tc-MIBI and 99m Tc-Tetrofosmin Myocardial Perfusion SPECT/CT Clin Nucl Med, 2026 Long-term Prognostic Value of Stress Phase Entropy for Predicting Major Cardiac Events in Patients with Known or Suspected Coronary Artery Disease Intern Med, 2026 Recent Progress in PET and SPECT Myocardial Perfusion Imaging: From Radiopharmaceuticals to Imaging Innovations Iran J Pharm Res, 2026 Quantitative and semi-quantitative comparison of myocardial blood flow between (99m)Tc-tetrofosmin and (99m)Tc-sestamibi: based on continuous rapid dynamic imaging technology using cadmium-zinc-telluride cardiac single-photon emission computed tomography Quant Imaging Med Surg, 2026 Challenges in Cardiac Risk Stratification for Bariatric Surgery: A Single-Centre Experience Obes Surg, 2026 Correction: Quality and pratical determinants in [(99m)Tc]Tc-tetrofosmin preparation: hygrometry, syringe sorption & maximal activity per kit EJNMMI Radiopharm Chem, 2026 Platform-specific impact of CT attenuation correction on CZT myocardial perfusion SPECT: per-vessel detection of obstructive coronary artery disease Int J Cardiovasc Imaging, 2026 Sources: PubChem and PubMed (NCBI), ClinicalTrials.gov and CTIS registries, approvals recorded by the atlas. PubChem data as of 28 October 2026.
Cite this page Tetrofosmin. Theranostic Atlas, LaRadiopharmacie.fr. Data as of 27 October 2026. https://theranosticatlas.com/molecule/tetrofosmin/ (accessed [date]).
A monitoring tool with no regulatory value: check every item at its source.